جست‌وجوی استاد و پژوهشگر

Xinran Zhongمشاهده پروفایل

استادیار

• Adaptive Radiation Therapy
• Artificial Intelligence in Radiation Oncology
• Cone-Beam CT Guided Re-planning
• +۴ مورد دیگر

Xinran Zhong, Ph.D., is an Assistant Professor in the Department of Radiation Oncology at the University of Texas Southwestern Medical Center in Dallas, Texas. She joined the faculty in 2022 after completing the Medical Physics Residency program at UT Southwestern. Dr. Zhong earned her B.S. in biomedical engineering from Tsinghua University (Beijing, China) in 2014 and her Ph.D. in medical physics from the University of California, Los Angeles in 2019. Her graduate and residency training focused on advanced imaging and computational methods for radiation oncology. Her research program integrates artificial intelligence, deep learning, and imaging physics to advance adaptive radiation therapy. Core themes include: Online adaptive replanning using cone-beam CT. AI-driven automatic segmentation and deformable registration. Personalized treatment planning for head-and-neck, cervical, and prostate cancers. Quality assurance strategies for adaptive workflows. Across 27 peer-reviewed publications (2018-2025), her work demonstrates a consistent trajectory toward clinical translation of AI tools that reduce contouring uncertainty, shorten planning times, and improve dosimetric outcomes. Studies span in silico simulations, prospective clinical registries, and feasibility trials. Dr. Zhong is an active member of professional societies including the American Association of Physicists in Medicine (AAPM) and the American Society for Radiation Oncology (ASTRO). She currently mentors trainees within the Radiation Oncology and Medical Physics Residency programs at UT Southwestern and participates in multidisciplinary tumor boards for head-and-neck, gynecologic, and genitourinary malignancies.

Tingliang Zhuangمشاهده پروفایل

دانشیار

• Adaptive Radiotherapy
• Cone-Beam CT Image Reconstruction
• Image-Guided Radiation Therapy (IGRT)
• +۳ مورد دیگر

Tingliang Zhuang, Ph.D. is an Associate Professor in the Department of Radiation Oncology at UT Southwestern Medical Center , where he contributes to both research and teaching. His academic journey began with a bachelor's degree in Electrical Engineering from Nanjing University , followed by a Ph.D. in Medical Physics at the University of Wisconsin-Madison . Education: B.S. in Electrical Engineering, Nanjing University Ph.D. in Medical Physics, University of Wisconsin-Madison Dr. Zhuang’s research interests span adaptive radiotherapy, cone-beam CT (CBCT) image reconstruction, image-guided radiation therapy (IGRT), treatment planning, and dosimetry. A significant focus of his work involves leveraging artificial intelligence to enhance therapeutic precision. His research has led to over 30 publications in journals like Medical Physics and International Journal of Radiation Oncology Biology Physics , addressing topics such as dose calculation algorithms, stereotactic body radiation therapy (SBRT), and adaptive treatment strategies for lung, spine, and prostate cancers. The 15 most recent articles in his publication record emphasize advancements in adaptive radiotherapy, CBCT-guided dose optimization, and AI-driven outcome prediction. These works often compare traditional methods (e.g., pencil beam vs. Monte Carlo simulations) and explore dosimetric impacts of tumor localization, organ motion, and delivery accuracy. In teaching , Dr. Zhuang has co-lectured medical physics residents at UT Southwestern, covering imaging in medicine and clinical rotation courses. His collaborations with institutions like Varian Medical Systems and UT Southwestern Medical Center highlight his translational approach to medical physics.

Sigbjørn Smelandمشاهده پروفایل

استاد

• Cancer Research
• Colorectal Cancer
• Osteosarcoma
• +۵ مورد دیگر

Sigbjørn Smeland is a Professor at the University of Oslo affiliated with the Division of Cancer Medicine . His research focuses on nutritional interventions in colorectal cancer patients, DNA damage biomarkers, and precision oncology implementation in Norway. He leads studies on diet-oxidative stress interactions and body composition changes post-cancer treatment. Key Research Areas : Cancer metabolism, DNA repair in oncology, clinical nutrition, precision medicine implementation Recent Trends : Dietary impact on DNA oxidation (2023-2025 studies), precision oncology frameworks (2024), MPNST transcriptomics (2023) Smeland contributes to Scandinavian Sarcoma Group trials and EURAMOS-1 collaborative research. His work appears in high-impact journals like Free Radical Biology & Medicine and The Lancet Oncology .

Nico van den Bergمشاهده پروفایل

استاد

• Medical Imaging
• Artificial Intelligence
• MRI Physics
• +۳ مورد دیگر

Professor Nico van den Berg is a Full Professor at the University Medical Center Utrecht, leading the Computational Imaging group within the Centre of Image Sciences. His research focuses on advancing MRI diagnostics and therapy through interdisciplinary expertise in MR physics, mathematics, computing, and artificial intelligence. Primary Affiliation: Centre of Image Sciences, University Medical Center Utrecht External Role: Scientific Advisor at PrecorDx His research initiatives target high-precision cancer and cardiovascular disease detection, prediction, and treatment. Key projects include: Development of MR-STAT for quantitative MRI in reduced scan times Integration of AI with MRI for personalized radiotherapy planning Hardware engineering for MRI-linac compatibility Respiratory motion compensation in cardiac MRI Publications highlight applications in prostate cancer (PET-MRI fusion), lung cancer (adaptive segmentation), and cardiovascular imaging. Collaborations span multiple strategic programs including Cancer, Brain Developmental disorders, and Image-Guided Therapies.

Jochem van der Voort van Zypمشاهده پروفایل

دانشیار

• Prostate Cancer
• MRI-guided Radiotherapy
• Radiation Oncology
• +۱ مورد دیگر

Jochem van der Voort van Zyp is an Associate Professor at Utrecht University , specializing in Radiation Oncology with a focus on Prostate Cancer and MRI-guided Radiotherapy . He is affiliated with the UMC Utrecht (University Medical Center Utrecht) and actively contributes to research in high-precision cancer therapies. Key Research Areas: Prostate Cancer, MR-guided Radiotherapy, Radiation Oncology, Medical Imaging Institution: Utrecht University / UMC Utrecht Contact: jvoortva@umcutrecht.nl His work explores advanced workflows for adaptive radiotherapy using integrated MRI-linear accelerator systems, aiming to reduce treatment toxicity while maintaining oncological outcomes. Recent publications (2025) analyze dose-volume parameters, geometric coverage, and acute toxicity in prostate cancer patients treated with 1.5 Tesla MR-linac technology.

James C. Millerمشاهده پروفایل

دانشیار

• Neurosurgery
• Brain Metastases
• Radiosurgery
• +۳ مورد دیگر

Dr. James C. Miller is an Associate Professor of Clinical Neurological Surgery at Indiana University School of Medicine and a Goodman Campbell Education Scholar in Neurological Surgery. He practices at the IU Health Neuroscience Center in Indianapolis, Indiana, where he specializes in the treatment of brain metastases using advanced radiosurgery techniques. Dr. Miller's research focuses on several key areas within neurosurgery and neuro-oncology: Treatment of brainstem metastases using Gamma Knife stereotactic radiosurgery Management of brain metastases from germ cell tumors Novel delivery methods bypassing the blood-brain and blood-tumor barriers Efficacy of postoperative seizure prophylaxis in brain tumor resections Treatment of spinal metastases using stereotactic body radiotherapy His publication record spans over three decades, with recent work including studies on CRISPR/Cas9 genome editing applications and comprehensive reviews of brain metastases management. Dr. Miller's research demonstrates a consistent focus on improving treatment outcomes for patients with complex neurological cancers. Notable professional recognition includes being named a Goodman Campbell Education Scholar in Neurological Surgery, highlighting his contributions to both clinical practice and medical education in the field. Dr. Miller maintains an active clinical practice at the IU Health Neuroscience Center while continuing to advance research in neurosurgical oncology through collaborations with multidisciplinary teams across Indiana University Health.

• Medical Imaging
• Nuclear Medicine
• Oncology
• +۴ مورد دیگر

Jukka Kemppainen is a Professor in the Department of Imaging and Clinical Diagnostics at the University of Turku, Faculty of Medicine, Finland. His research bridges nuclear medicine, oncology, and artificial intelligence to develop advanced cancer diagnostics. His core research domains include: Medical Imaging & Nuclear Medicine (PSMA/FDG PET, MRI) AI-Driven Oncology (prostate, pancreatic, head-neck cancers) Deep Learning Applications (convolutional neural networks for segmentation/classification) Theranostics Development & Biobank Research Recent publications (2023-2025) demonstrate a clear trajectory toward AI-enhanced precision oncology, with increasing focus on real-world clinical implementation. His work frequently appears in high-impact surgical and nuclear medicine journals, emphasizing multi-institutional Finnish collaborations. Professor Kemppainen maintains active clinical-academic engagement through the University of Turku, with direct contact available at jukkem@utu.fi .

Nicole Simoneمشاهده پروفایل

استاد

• Breast Cancer
• Radiation Oncology
• Prostate Cancer
• +۴ مورد دیگر

Nicole Simone, MD is the Margaret Q. Landenberger Professor in the Department of Radiation Oncology at Sidney Kimmel Medical College, Thomas Jefferson University. As a board-certified radiation oncologist, she specializes in breast cancer treatment and conducts clinical trials to minimize radiation side effects while optimizing therapeutic efficacy. Her research focuses on: Caloric restriction combined with radiation therapy for hormonally responsive cancers Long-term radiation toxicity in breast cancer patients Novel cardioprotective and pulmoprotective techniques during radiotherapy Dr. Simone leads an active research laboratory studying tumor growth and metastasis inhibition through diet-radiation synergies. She collaborates extensively with radiologists, pathologists, surgeons, and medical oncologists in multidisciplinary care teams and participates in national clinical trials to integrate cutting-edge cancer treatments into patient care.

Tufve Nyholmمشاهده پروفایل

استاد

• Radiotherapy
• Medical Imaging
• Artificial Intelligence
• +۵ مورد دیگر

Tufve Nyholm serves as Professor in Radiation Physics at Umeå University with a joint appointment as Medical Physicist at the University Hospital of Northern Sweden. He holds the position of Head of Department within the Department of Diagnostics and Intervention, specifically leading the Section of Biomedical Engineering and Radiation Physics under Oncology. His work bridges clinical radiotherapy applications with advanced imaging research, operating from Location 10C at Norrlands Universitetssjukhus in Umeå. His primary research focuses on medical imaging modalities including Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), with strong emphasis on prostate cancer applications. The research integrates artificial intelligence for image analysis, segmentation, and uncertainty estimation to optimize radiotherapy treatment planning. Key initiatives explore correlations between clinical imaging, histopathology, and molecular risk markers to enable personalized radiotherapy solutions. The work spans both technical development of AI tools and clinical validation studies through multi-disciplinary collaboration. Publication trends reveal consistent focus on AI-driven solutions for radiotherapy challenges, particularly in prostate and cervical cancers. Recent work emphasizes resource-efficient AI segmentation, MR-only radiotherapy protocols, and quantitative imaging biomarkers. The research demonstrates strong clinical translation with frequent co-authorship from oncologists, radiologists, and pathologists, reflecting integrated team science approaches. Nyholm leads the Tufve Nyholm Lab research group comprising associate professors, medical physicists, and doctoral students. Current projects include AI-based delineation in radiotherapy (2024-2026), quantitative MRI for individualized radiotherapy (2023), pediatric radiotherapy automation (2022-2024), and the PAMP prostate cancer study. The group receives external funding from the Swedish Cancer Society, Cancerforskningsfonden Norrland, Region Västerbotten, and Prostatacancerförbundet. The lab maintains extensive collaborations across Umeå University including Oncology (Karin Söderkvist, Camilla Thellenberg Karlsson, Björn Zackrisson), Pathology (Anders Bergh), Radiology (Sara Strandberg, Katrine Riklund), Urology (Andreas Josefsson), and Computer Science (Tommy Löfstedt, Polina Kurtser). This multi-disciplinary network enables comprehensive research from molecular markers to clinical implementation.

• Positron Emission Tomography (PET) Imaging
• Molecular Imaging
• Neuroinflammation
• +۳ مورد دیگر

Moses Quinn Wilks is an Assistant Professor in the Radiology & Biomedical Imaging department at Yale School of Medicine , affiliated with the Division of Bioimaging Sciences and PET Core Radiology . He holds a PhD in Biomathematics from the University of California, Los Angeles. Research Focus: Development of PET tracers for demyelination, neuroinflammation, and macrophage-specific arterial imaging; nanotechnology applications in dual-mode PET-MR imaging; and HIV-related vascular complications. Key Collaborations: Georges El Fakhri, Marc Normandin, Nicolas Guehl, and David Alagpulinsa. Publication Trends: Recent work emphasizes in-silico modeling of radiopharmaceutical effects in prostate cancer, HIV-associated vascular inflammation, and innovative tracer synthesis techniques. Keywords span Radiology , Neuroscience , and Nanomedicine . Contact: moses.wilks@yale.edu

Jing Qianمشاهده پروفایل

پژوهشگر

• Proton Therapy
• Clinical Therapeutical Physics
• Quantitative Image Analysis
• +۵ مورد دیگر

Dr. Jing Qian, Ph.D., is a medical physicist in the Department of Radiation Oncology at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota. He holds an appointment at Mayo Clinic College of Medicine and is board-certified in Therapeutic Medical Physics by the American Board of Radiology. His clinical expertise focuses on proton therapy and improving radiation treatment delivery efficiency, outcomes, and safety. Dr. Qian completed his Doctor of Philosophy in Physics at Yale University in 2009 and finished his residency in Radiation Oncology Medical Physics at Mayo Clinic in 2021. His early academic achievements include Yale University's Henry Fan Family Fellowship and Leigh Page Prize in 2002. His research spans proton therapy optimization, quantitative image analysis, and artificial intelligence applications in radiation oncology. Recent work demonstrates his shift toward developing deep learning models for proton dose calculation, analyzing imaging signatures for treatment response prediction, and optimizing treatment delivery systems. His interdisciplinary approach bridges physics, oncology, and computer science to improve cancer treatment outcomes. Dr. Qian's publication record shows consistent output in high-impact journals with an increasing focus on AI-driven solutions for radiation therapy challenges. His collaborative work spans multiple institutions and clinical specialties, reflecting the interdisciplinary nature of modern medical physics research. 2024 Distinguished Physics Researcher, Mayo Clinic Department of Radiation Oncology 2022 Mayo Scholar, Google Visiting Scholar Multiple beOUTSTANDING awards from Schlumberger Corporation (2014-2017) Outstanding Contributor and Most Valued Reviewer for Radiation Measurements journal Yale University's Henry Fan Family Fellowship and Leigh Page Prize (2002) Dr. Qian actively mentors physics residents and postdoctoral fellows, contributing to the next generation of medical physicists. His work with Mayo Clinic's Comprehensive Cancer Center provides access to advanced proton therapy facilities and cutting-edge research infrastructure. His collaborations extend to Google researchers and multiple clinical departments within Mayo Clinic, creating a rich environment for translational medical physics research. His laboratory work focuses on developing and validating new technologies for radiation treatment delivery and outcome prediction. Current projects involve AI-driven optimization of proton therapy systems, radiomics analysis of treatment response, and improving the precision of radiation dose delivery while minimizing toxicity.

• Radiogenomics
• Radiation Oncology
• Normal Tissue Toxicity
• +۵ مورد دیگر

Sarah L. Kerns, PhD, is an Associate Professor in the Department of Radiation Oncology at the Medical College of Wisconsin. She holds a BS from the University of Wisconsin-Madison, PhD from Northwestern University, and MPH from Johns Hopkins. Her affiliations include former faculty positions at the University of Rochester and Icahn School of Medicine at Mount Sinai, with active roles in the International Radiogenomics Consortium (Co-Lead) and NCI steering committees. Her research integrates radiogenomics, toxicity prediction modeling, and cancer survivorship, with emphases on: Genetic biomarkers for radiation-induced injury Cisplatin toxicity mechanisms in testicular cancer Inflammatory pathways in cancer-related symptoms Multi-ancestry genomic equity in risk assessment Her publications focus on translating genomic discoveries into clinical tools for personalizing radiotherapy, with recent work on extracellular vesicle proteomics, epigenetic regulators of fibrosis, and polygenic risk scores. Research trends show strong emphasis on prostate cancer toxicity mechanisms, large-scale GWAS meta-analyses, and imaging-genomic correlations. Awards include: NIH Clinical Loan Repayment Award (2017-2021) ASTRO Annual Meeting Award (2010) Predoctoral Fellowship, Chicago Baseball Cancer Charities (2004-2007) She mentors junior faculty and leads NIH-funded projects on biobanking and omega-3 supplementation mechanisms. She directs collaborative initiatives at the Center for Cancer Discovery and oversees genomic components of national consortia like REQUITE.

• Cancer disparities
• Health behaviors in cancer survivors
• Lifestyle interventions for cancer survivors
• +۷ مورد دیگر

Dr. Melinda Stolley is a Professor of Medicine in the Hematology/Oncology Division at the Medical College of Wisconsin (MCW), where she also serves as the Associate Director of Population Sciences for the Cancer Center. With over 25 years of academic experience, she has held faculty positions at Northwestern University and the University of Illinois Chicago before joining MCW in 2015. Dr. Stolley's work focuses on addressing cancer disparities through community-engaged research, particularly with African American and Latino communities in Milwaukee. Dr. Stolley's research interests center on health behaviors and lifestyle interventions for cancer survivors, with a specific focus on minority and underserved populations. Her work examines how diet, physical activity, and social determinants of health impact cancer outcomes, particularly for breast and prostate cancer survivors. She has developed and tested several culturally tailored interventions including 'Men Moving Forward' for African American prostate cancer survivors and 'Everyday Counts' for women with metastatic breast cancer. Her approach emphasizes community partnership and cultural relevance to ensure interventions are acceptable and effective for the populations they serve. Dr. Stolley's recent publications demonstrate a consistent focus on addressing cancer disparities through innovative community-engaged approaches. Her work spans multiple cancer types but maintains a consistent theme of adapting evidence-based interventions to meet the specific needs of minority populations. This includes examining social determinants of health, developing culturally appropriate educational materials, and creating sustainable community partnerships to improve cancer outcomes. Dr. Stolley has received several prestigious awards recognizing her contributions to research and mentorship: 2024 President's Community Engagement Award, Medical College of Wisconsin 2023 Society of Research Excellence, Medical College of Wisconsin 2020 Michael J. Dunn Award for Research Excellence 2020 President's Diversity and Inclusion Award 2019 Ann E. Heil Endowed Professorship in Cancer Research 2018 Magnanimous Mentor Award As an active researcher, Dr. Stolley has secured significant funding from the National Cancer Institute, American Heart Association, and other sources to support her work addressing cancer disparities. Her current major grants include 'Men Moving Forward' (R01CA229546), 'Everyday Counts' (R01CA258759), and the 'Biobehavioral Oncology Training Program' (T32CA269115). She has mentored numerous students and post-doctoral fellows, many of whom have gone on to successful academic careers. Her work bridges the gap between academic research and community needs, creating meaningful impact in reducing cancer disparities in Wisconsin and beyond.

• Nuclear Medicine
• Thyroid Cancer Imaging
• PET/CT Diagnostics
• +۴ مورد دیگر

Funda ÜSTÜN is a Professor at Trakya University Medical Faculty's Department of Nuclear Medicine with extensive expertise in molecular imaging applications for cancer diagnostics and therapy. Her clinical and research focus centers on thyroid cancer imaging, prostate cancer diagnostics using PSMA-targeted radiopharmaceuticals, and sarcoma research. Her research interests span Nuclear Medicine, Thyroid Cancer Imaging, PET/CT Diagnostics, Prostate Cancer Imaging, Radiopharmaceutical Development, Sarcoma Research, and Molecular Imaging. She investigates advanced imaging techniques for cancer characterization, develops novel radiopharmaceuticals for targeted therapy, and applies machine learning to improve cancer risk stratification. Her work bridges nuclear medicine with oncology, endocrinology, and nanotechnology to enhance diagnostic accuracy and therapeutic outcomes. Her recent publications demonstrate strong trends in precision oncology, with emphasis on PSMA imaging for prostate cancer, thyroid cancer recurrence prediction using AI, and nanoparticle-based drug delivery systems. Key research areas include radiopharmaceutical development, molecular imaging biomarkers, and quantitative imaging analysis for tumor characterization. As an academic advisor, she has supervised multiple master's theses focusing on PET/CT applications in prostate cancer, lung metastasis prediction, and parathyroid scintigraphy. Her editorial and referee work includes contributions to MIRT (Molecular Imaging and Radiotherapy). Her laboratory and research team focus on preclinical radiopharmaceutical development, molecular imaging techniques, and translational applications of nuclear medicine in oncology. Current projects involve nanoparticle-based drug delivery systems, radiolabeling techniques, and advanced PET/CT quantification methods for cancer diagnostics.

Adam P. Dickerمشاهده پروفایل

استاد

• Radiation Oncology
• Translational Cancer Research
• Prostate Cancer
• +۴ مورد دیگر

Adam P. Dicker is Professor and Chair of the Department of Radiation Oncology at Thomas Jefferson University, with joint appointments in Pharmacology and Experimental Therapeutics. His mission, "Empowering patients through translational cancer research," drives his leadership of an interdisciplinary team focused on defining fundamental mechanisms for combined modality radiation treatment and translating innovations to clinical cancer care. His research spans radiation oncology, prostate cancer biology, and translational medicine. Key contributions include defining edema's influence on prostate brachytherapy dosimetry, correlating radiotherapy protocol deviations with survival outcomes (JNCI, 2012), investigating "self-seeding" metastasis mechanisms, and developing "smart needles" for diagnostic/therapeutic applications. He pioneers signal transduction agent-radiation combinations and first-in-human developmental therapeutic trials. Dr. Dicker received the Fellow of ASTRO (FASTRO) designation in 2014 for exceptional contributions to research, education, patient care, and leadership in radiation oncology. He has mentored over 40 residents, many now established clinician-scientists globally. As Principal Investigator of a DoD Prostate Synergy Grant and recipient of Prostate Cancer Foundation funding, his work bridges preclinical discovery with clinical implementation through NRG Oncology and RTOG frameworks. He coordinates Jefferson's radiation oncology research team and co-chairs NRG Oncology's Translational Science Committee, directing the Integrated Translational Genoproteomics Center initiative. His authority spans solid tumor translational research with emphasis on predictive biomarkers, preclinical models, and molecular signatures for clinical trial development.